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“Percutaneous Lumbar Decompression Improves Quality of Life in
Veterans Suffering from Low Back and Leg Pain”
Michael Forte,L2, Casey Murphy, M.D., Randolph Roig, M.D., Carlos Trigo M.D., Thomas Finke M.D.

Results

Introduction
Interspinous process decompression (IPD) is a
procedure that limits lumbar spine extension
through implantation of a spacer between
adjacent spinous processes to mitigate moderate
intermittent neurogenic claudication symptoms
associated with lumbar spinal stenosis (LSS).
Our study aims to determine whether
percutaneous IPD provides relief to United
States Military Veterans who have undergone
the procedure over the past year. To determine
this, a health survey and a secondary
questionnaire will compare pre-operative and
post-operative results

Using the SF-12v2, patients saw an average increase of
6.56 in their MCS score (p>0.05), while the change
recorded in the PCS score was insignificant (p>0.05).
Regarding the secondary survey, patients had an
average decrease of -1.69 in their pain score on the
standardized 10-point pain scale (p=0.078, p>0.05).
Additionally, patients saw an average increase of 2.04
blocks walked post-procedure (p=0.087, p>0.05).
Patients taking opiates before the procedure had an
average decrease of -23.09 morphine milliequivalents
post-op (p=0.024, p<0.05). Subsequently, only 7 (43.75%)
patients received procedures after Vertiflex, consisting of
1 (14.29%) patient with back surgery, 6 (85.71%) of
these patients receiving epidural steroid injections, and 0
patients undergoing a Vertiflex explant.

Results Continued

Figure 2: Patients response when asked whether they
would recommend Vertiflex to a fellow Veteran (n=16)

Methods
Patients were administered an SF-12v2 survey
pre-operatively and at several intervals up to 1year post-operatively to assess their quality of
life over time; there is a score for Mental
Component Summary (MCS) and Physical
Component Summary (PCS). The patients were
then administered a customized secondary
questionnaire to specifically monitor their
improvement in pain on a scale of 1-10 and
their improvement in the number of blocks
walked post-operatively. Opioids taken
chronically were measured before and after the
procedure; our conversion of hydrocodone to
morphine was 1:1, and oxycodone to morphine
was 1.5:1. The patients were also questioned on
whether they received any post-operative
injections, lumbar surgeries, and IPD explants.
Additionally, the patients were asked whether
they would recommend Vertiflex, IPD, to a
fellow veteran. 20 patients are currently
participating in the study, and 16 patients have
been assessed at the 1-year time mark.

Figure 1: Mean PCS and MCS of patients before their
operation and 1-year post-operation (n=16)

Figure 3: Mean pain score and number of blocks walked
without pain before and after Vertiflex procedure (n=16)

Conclusion
Percutaneous lumbar decompression with IPD increases
the quality of life in Veterans. A significant decrease in
chronic opioid use was seen after IPD. A majority of
patients recommend IPD to fellow U.S. Veterans, and
there were no complications.

This research project was supported through the LSU Health Sciences Center, School of Medicine.

